Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pocard

Showing results (231-240 of 277) with videos related to

Pageof 28
Sort By:
Annals of Surgical Oncology|September 27, 2025
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma PatientsJulien Péron, Ismail Essadi, Pascal Rousset, et al.
Annals of Surgery|July 19, 2016
Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC)Julie Perinel, Christophe Mariette, Bertrand Dousset, et al.
Cancers|September 28, 2021
Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based ImmunotherapyJimmy Stalin, Beat A Imhof, Oriana Coquoz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 5, 2024
Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: Results from two French expert centersAnne-Cécile Ezanno, Sihame Chkair, Jean-Louis Quesada, et al.
Frontiers in Physiology|August 20, 2021
Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor DiseasesMatthias Barral, Imane El-Sanharawi, Anthony Dohan, et al.
Annals of Surgical Oncology|October 27, 2017
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?Guillaume Passot, Bradford J Kim, Olivier Glehen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2024
PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trialFrédéric Dumont, Vahan Kepenekian, Christophe Passot, et al.
Cancer Research|January 11, 2007
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line featuresVirginie Dangles-Marie, Marc Pocard, Sophie Richon, et al.
The Journal of Clinical Investigation|March 5, 2013
MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injuryNicolas Deroide, Xuan Li, Dominique Lerouet, et al.
Anticancer Research|August 9, 2015
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian CancerJean-Marc Classe, Olivier Glehen, Evelyne Decullier, et al.
Pageof 28

Showing results (231-240 of 277) with videos related to

Sort By:
Pageof 28
Annals of Surgical Oncology|September 27, 2025
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma PatientsJulien Péron, Ismail Essadi, Pascal Rousset, et al.
Annals of Surgery|July 19, 2016
Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC)Julie Perinel, Christophe Mariette, Bertrand Dousset, et al.
Cancers|September 28, 2021
Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based ImmunotherapyJimmy Stalin, Beat A Imhof, Oriana Coquoz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 5, 2024
Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: Results from two French expert centersAnne-Cécile Ezanno, Sihame Chkair, Jean-Louis Quesada, et al.
Frontiers in Physiology|August 20, 2021
Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor DiseasesMatthias Barral, Imane El-Sanharawi, Anthony Dohan, et al.
Annals of Surgical Oncology|October 27, 2017
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?Guillaume Passot, Bradford J Kim, Olivier Glehen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2024
PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trialFrédéric Dumont, Vahan Kepenekian, Christophe Passot, et al.
Cancer Research|January 11, 2007
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line featuresVirginie Dangles-Marie, Marc Pocard, Sophie Richon, et al.
The Journal of Clinical Investigation|March 5, 2013
MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injuryNicolas Deroide, Xuan Li, Dominique Lerouet, et al.
Anticancer Research|August 9, 2015
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian CancerJean-Marc Classe, Olivier Glehen, Evelyne Decullier, et al.
Pageof 28